OxyContin Maker Purdue Pharma to Dissolve, Redirect to Public Good After Settlement

TL;DR Summary
Purdue Pharma is set to dissolve and be replaced by a public-interest company as a sweeping settlement resolves thousands of opioid-related lawsuits. The Sackler family could contribute up to $7 billion over 15 years, while the federal government will collect $225 million of an $8.3 billion forfeiture; total settlements exceed $50 billion with most funds going to government efforts to fight opioids. Individual victim payments are expected to be about $8,000–$16,000, and protests were held outside Newark’s federal courthouse as families seek justice.
- Purdue Pharma, maker of OxyContin, set to dissolve after judge approves its criminal sentence CBS News
- Purdue Pharma receives $5.5 billion sentence, paving way for opioid settlement CNBC
- Judge OKs OxyContin maker Purdue Pharma's criminal sentence, a last step before it dissolves NBC News
- “A Punch in the Gut”: After Years of Waiting, Many Opioid Victims Will Be Shut Out of Purdue Settlement ProPublica
- Purdue Pharma to pay more than $8bn to end US opioid case Financial Times
Reading Insights
Total Reads
0
Unique Readers
8
Time Saved
3 min
vs 4 min read
Condensed
88%
697 → 83 words
Want the full story? Read the original article
Read on CBS News